PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
12821347-6	2003	Treatment with the maximum tolerated doses of DFO, L1, or starch-DFO conjugate induced no significant iron deprivation in non-iron-overloaded mice, while an iron-poor diet led to a dramatic decrease in serum iron, transferrin iron saturation, and ferritin levels.	Deferoxamine	46-49	transferrin	Mus musculus	214-225	
20463304-5	2010	DFO treatment of apoE-/- mice also lowered serum levels of MCP-1 and gene expression of proinflammatory and macrophage markers in the aorta and heart, in parallel with increased protein expression of the transferrin receptor in the heart and liver.	Deferoxamine	0-3	transferrin	Mus musculus	204-215	
12821347-6	2003	Treatment with the maximum tolerated doses of DFO, L1, or starch-DFO conjugate induced no significant iron deprivation in non-iron-overloaded mice, while an iron-poor diet led to a dramatic decrease in serum iron, transferrin iron saturation, and ferritin levels.	Deferoxamine	65-68	transferrin	Mus musculus	214-225	
7641199-1	1995	Synergistic inhibition of hematopoietic tumor growth can be observed in vitro when the iron chelator deferoxamine (DFO) is used in combination with an IgG mAb against the anti-transferrin receptor antibody (ATRA).	Deferoxamine	101-113	transferrin	Mus musculus	176-187	
7641199-1	1995	Synergistic inhibition of hematopoietic tumor growth can be observed in vitro when the iron chelator deferoxamine (DFO) is used in combination with an IgG mAb against the anti-transferrin receptor antibody (ATRA).	Deferoxamine	115-118	transferrin	Mus musculus	176-187	
2858272-2	1985	The growth promoting action of transferrin was lost when iron was chelated in the culture medium using desferrioxamine.	Deferoxamine	103-118	transferrin	Mus musculus	31-42	
6296362-1	1983	One of the most efficient anions in enhancing the ability of desferrioxamine (DFO) to remove iron from transferrin in vitro has been shown to be pyrophosphate (PYP).	Deferoxamine	61-76	transferrin	Mus musculus	103-114	
6296362-1	1983	One of the most efficient anions in enhancing the ability of desferrioxamine (DFO) to remove iron from transferrin in vitro has been shown to be pyrophosphate (PYP).	Deferoxamine	78-81	transferrin	Mus musculus	103-114	
6296362-11	1983	The kind of iron with which DFO + PYP interacts is then suggested to be the transferrin-bound iron located in extracellular spaces of tissues.	Deferoxamine	28-31	transferrin	Mus musculus	76-87	
10397746-4	1999	Ligand 311 was far more active than DFO at increasing Fe release from SK-N-MC neuroepithelioma and BE-2 neuroblastoma cells and preventing Fe uptake from transferrin.	Deferoxamine	36-39	transferrin	Mus musculus	154-165